Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
Martin-Algarra, S
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. [electronic resource] - Experimental hematology Dec 1995 - 1503-8 p. digital
Publication Type: Journal Article
0301-472X
Adult
Aged
Bone Marrow Transplantation
Cyclophosphamide--therapeutic use
Etoposide--therapeutic use
Female
Graft vs Host Disease--prevention & control
Granulocyte Colony-Stimulating Factor--therapeutic use
Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use
Histocompatibility
Humans
Leukemia--mortality
Male
Methotrexate--therapeutic use
Middle Aged
Recombinant Proteins--therapeutic use
Recurrence
Survival Rate
Transplantation, Homologous
Treatment Outcome
Whole-Body Irradiation
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis. [electronic resource] - Experimental hematology Dec 1995 - 1503-8 p. digital
Publication Type: Journal Article
0301-472X
Adult
Aged
Bone Marrow Transplantation
Cyclophosphamide--therapeutic use
Etoposide--therapeutic use
Female
Graft vs Host Disease--prevention & control
Granulocyte Colony-Stimulating Factor--therapeutic use
Granulocyte-Macrophage Colony-Stimulating Factor--therapeutic use
Histocompatibility
Humans
Leukemia--mortality
Male
Methotrexate--therapeutic use
Middle Aged
Recombinant Proteins--therapeutic use
Recurrence
Survival Rate
Transplantation, Homologous
Treatment Outcome
Whole-Body Irradiation